Start Date
September 30, 2020
Primary Completion Date
October 26, 2023
Study Completion Date
October 26, 2023
PF-06826647 100 mg QD
Investigational Product
PF-06826647 300 mg QD
Investigational Product
PF-06826647 600 mg QD
Investigational Product
Placebo
Matched Placebo
PF-6826647 400 mg QD
Investigational Product
Gastroenterolgy Associates of Northern Virginia, Fairfax
Gastroenterology Associates of Northern Virginia, Fairfax
Verity Research, Inc., Fairfax
Fair Oaks Imaging Center- Reston Radiology Consultants, Fairfax
Associates in Gastroenterology (c/o TrialSpark, inc), Woodbridge
Gastroenterology Consultants P.C., Roswell
Saludmax Medical Corp., Miami
Alliance Clinical Research of Tampa, Tampa
Internal Medicine Associates (c/o TrialSpark, Inc.), Merrillville
Physicians Ambulatory Surgery Center, LLC, dba Physicians Endoscopy Center, Houston
Houston Digestive Diseases Consultants, P.A., Houston
Memorial Hermann SW Surgery Center, Houston
Sugar Lakes Family Practice, PA, Sugar Land
Gastroenterology Consultants of San Antonio, San Antonio
Victorium Clinical Research, San Antonio
South Texas Radiology Imaging Center, San Antonio
ADVA Clinical Research, Inglewood
Centinela Valley Endoscopy Center, Inglewood
Inglewood Imaging Center, Inglewood
Hope Clinical Research, Canoga Park
Renaissance Imaging Center (CT/Xray), Northridge
Valley Endoscopy Center (Colonoscopy/Flexible sigmoidoscopy), Tarzana
Surinder Saini, M.D., Inc., Newport Beach
Gastroenterology Associates of New Jersey, LLC (c/o TrialSpark, Inc.), Clifton
Lead Sponsor
Pfizer
INDUSTRY